Acerus Pharmaceuticals Corporation Aktie Toronto S.E.
Aktien
A3DHGW
CA00444G4051
ASP
Pharmazeutika
Manager | Titel | Alter | Seit |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01.05.18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17.07.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09.09.13 |
Borys Chabursky
BRD | Director/Board Member | - | 20.12.15 |
% 1. Jan. | Kap. | |
---|---|---|
+21,85 % | 546 Mrd. | |
-4,77 % | 359 Mrd. | |
+16,97 % | 323 Mrd. | |
+5,69 % | 290 Mrd. | |
+13,68 % | 234 Mrd. | |
+3,65 % | 198 Mrd. | |
-11,12 % | 194 Mrd. | |
+8,08 % | 167 Mrd. | |
-3,40 % | 157 Mrd. |